Clinical decisions
Empagliflozin: ketoacidosis can hide behind modest glucose
A glucose that is not markedly elevated can distract from ketoacidosis in an SGLT 2-treated patient. Nausea, vomiting, abdominal pain, malaise or shortness of breath can require urgent assessment despite a lower-than-expected glucose.
Sources checked October 5, 2026. Independent educational content, not NABP exam questions or individual treatment advice.
Do not use glucose as a safety clearance
The label describes ketoacidosis with glucose below 250 mg/dL. Reduced intake, surgery, volume depletion and insufficient insulin may contribute. A glucose reading does not establish or exclude acidosis or ketonemia.
Concerning symptoms need prompt assessment and appropriate laboratory evaluation. Euglycemic is a reminder about possible presentation, not a symptom-only diagnosis. Escalate rather than recommending home management for a potentially serious metabolic problem.
Plan before fasting begins
Withhold empagliflozin at least three days if possible before major surgery or procedures associated with prolonged fasting. Verify the exact product; this Jardiance-specific lesson does not replace checking another SGLT 2 inhibitor's instructions.
State last dose, procedure, any alternate glucose-management plan and who decides restart. Urgent surgery may not allow the full interval. That does not remove risk or the need for monitoring and clinical planning.
Restart depends on recovery
Resume when clinically stable and oral intake has resumed. If ketoacidosis occurred, monitor for resolution before restarting. A patient still fasting or vomiting does not meet the restart test merely because surgery has ended.
Review volume status, renal function and other medicines. Long-term heart or kidney benefits do not erase an acute safety issue. The lesson supports exam reasoning, not individual perioperative instructions.
Communicate a plan that survives transitions
The patient may receive instructions from surgery, primary care and a dispensing pharmacy. A vague "hold around surgery" can produce either continued exposure during fasting or an unnecessary long-term stop. Confirm who owns the plan and what clinical conditions permit restart.
For practice, divide the answer into before, during and after the procedure. Put the labeled interval before the procedure, the symptom and laboratory assessment during illness, and stability plus oral intake after. Do not reduce all three to one calendar date.
A worked case
An empagliflozin patient has vomiting and abdominal pain after prolonged fasting. Glucose is 180 mg/dL.
- Identify exposure, fasting and symptoms as a concerning combination.
- The label requires assessment regardless of glucose;180 does not exclude ketoacidosis.
- Escalate promptly and discontinue if suspected under the clinical pathway.
Answer: A modest glucose is not reassurance.
Try it before reading the answer
Write the key fact, decision and safety check first. These are original practice exercises, not recalled exam items.
1. What preoperative interval does Jardiance specify when possible?
At least three days before major surgery or prolonged-fasting procedures.
2. Can restart occur while the patient is still fasting?
Not under the stated conditions: clinical stability and resumed oral intake are required.
3. Does normal-looking glucose exclude this complication?
No. Assess regardless of glucose when there is clinical concern.
Continue learning
Put the topic into a study planSources and scope
Source dates and limits matter. Follow the current official source for clinical or regulatory decisions. Examples are simplified teaching cases, not prescribing, diagnostic or compounding instructions. Check the full current guidance and individual clinical context.